Rare diseases
Investigational molecules
Locations
239 conditions with trials, the busiest first
357 trials across Europe, recruiting first
Study on the Safety and Effects of UX701 Gene Therapy for Adults with Wilson Disease
DenmarkStudy on the Effects and Safety of Nicotinamide for Patients with Type 2 Diabetes and Liver Fibrosis
SpainStudy on Cisplatin, Gemcitabine, and Paclitaxel Albumin-Bound for Patients with Resectable Biliary Tract Cancer at High Risk of Recurrence
ItalyStudy on Long-Term Safety of Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease
AustriaStudy of DS-3939a for Patients with Advanced or Metastatic Solid Tumors
BelgiumStudy on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease
DenmarkStudy on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation
FranceStudy on the Effects of Cannabis Oil (Dronabinol and Cannabidiol) for Patients with Untreatable Advanced Liver Cancer
The NetherlandsStudy of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis
BulgariaSafety and Efficacy of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis: A Long‑Term Randomized Placebo‑Controlled Study
BulgariaStudy of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma
ItalyA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
BelgiumThe therapies tested most often in Hepatobiliary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
